000590 古汉医药
已收盘 01-07 15:00:00
资讯
新帖
简况
古汉医药：1月5日高管罗怀青增持股份合计10000股
证券之星 · 01-06 21:01
古汉医药：1月5日高管罗怀青增持股份合计10000股
古汉医药(000590.SZ)：全资子公司股权内部划转
中金财经 · 2025-12-30
古汉医药(000590.SZ)：全资子公司股权内部划转
启迪药业最新公告：证券简称拟变更为“古汉医药”
证券之星 · 2025-12-22
启迪药业最新公告：证券简称拟变更为“古汉医药”
启迪药业（000590）披露拟变更公司名称并修订《公司章程》议案获股东会通过，12月16日股价下跌2.83%
证券之星 · 2025-12-16
启迪药业（000590）披露拟变更公司名称并修订《公司章程》议案获股东会通过，12月16日股价下跌2.83%
启迪药业：通过产品及康养文旅服务对接养老产业链需求
证券之星 · 2025-11-27
启迪药业：通过产品及康养文旅服务对接养老产业链需求
启迪药业(000590.SZ)拟更名为“古汉医药集团股份公司”
智通财经 · 2025-11-26
启迪药业(000590.SZ)拟更名为“古汉医药集团股份公司”
启迪药业：可治疗流感症状的药品有7个产品批文
证券之星 · 2025-11-20
启迪药业：可治疗流感症状的药品有7个产品批文
启迪药业（000590）发布2025年第二次临时股东大会决议公告，11月18日股价下跌1.0%
证券之星 · 2025-11-18
启迪药业（000590）发布2025年第二次临时股东大会决议公告，11月18日股价下跌1.0%
股市必读：启迪药业（000590）11月10日董秘有最新回复
证券之星 · 2025-11-11
股市必读：启迪药业（000590）11月10日董秘有最新回复
启迪药业：取消变更公司名称议案
证券之星 · 2025-11-10
启迪药业：取消变更公司名称议案
启迪药业：公司目前没有筹划的定增事项
证券之星 · 2025-11-07
启迪药业：公司目前没有筹划的定增事项
股市必读：启迪药业三季报 - 第三季度单季净利润同比增长146.43%
证券之星 · 2025-10-31
股市必读：启迪药业三季报 - 第三季度单季净利润同比增长146.43%
图解启迪药业三季报：第三季度单季净利润同比增长146.43%
证券之星 · 2025-10-30
图解启迪药业三季报：第三季度单季净利润同比增长146.43%
10月23日启迪药业（000590）涨停分析：控股股东变更、业绩改善驱动
证券之星 · 2025-10-23
10月23日启迪药业（000590）涨停分析：控股股东变更、业绩改善驱动
启迪药业：暂无海外业务或出口收入
证券之星 · 2025-10-21
启迪药业：暂无海外业务或出口收入
启迪药业、盟科药业易主，医药行业加速洗牌
21世纪经济报道 · 2025-09-25
启迪药业、盟科药业易主，医药行业加速洗牌
启迪药业最新公告：独立董事黄正明因工作原因辞职
证券之星 · 2025-09-24
启迪药业最新公告：独立董事黄正明因工作原因辞职
启迪药业最新公告：总裁冯雪、副总裁蔡军辞职
证券之星 · 2025-09-22
启迪药业最新公告：总裁冯雪、副总裁蔡军辞职
启迪药业（000590）披露取消2025年第一次临时股东大会部分提案，9月17日股价上涨0.57%
证券之星 · 2025-09-17
启迪药业（000590）披露取消2025年第一次临时股东大会部分提案，9月17日股价上涨0.57%
启迪药业(000590.SZ)拟更名为“古汉养生健康产业集团股份公司”
智通财经 · 2025-09-05
启迪药业(000590.SZ)拟更名为“古汉养生健康产业集团股份公司”
加载更多
公司概况
公司名称：
古汉医药集团股份公司
所属行业：
医药制造业
上市日期：
1996-01-19
主营业务：
古汉医药集团股份公司的主营业务是医药大健康领域的拓展深耕，产品涵盖中药、化药、保健食品三大板块。公司的主要产品是补益养生类药品、心脑血管类药品、儿童营养类药品、感冒类药品、清热解毒类药品。公司为国家级绿色工厂、中国驰名商标、中华老字号、湖南省非物质文化遗产代表性名录、湖南省制造业质量标杆称号。
发行价格：
6.00
{"stockData":{"symbol":"000590","market":"SZ","secType":"STK","nameCN":"古汉医药","latestPrice":11.6,"timestamp":1767769425000,"preClose":11.74,"halted":0,"volume":4180100,"delay":0,"changeRate":-0.0119,"floatShares":239000000,"shares":239000000,"eps":-0.4671,"marketStatus":"已收盘","change":-0.14,"latestTime":"01-07 15:00:00","open":11.75,"high":11.8,"low":11.58,"amount":48712100,"amplitude":0.0187,"askPrice":11.6,"askSize":15,"bidPrice":11.59,"bidSize":114,"shortable":0,"etf":0,"ttmEps":-0.4671,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767835800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.74,"symbolType":"stock","openAndCloseTimeList":[[1767749400000,1767756600000],[1767762000000,1767769200000]],"highLimit":12.91,"lowLimit":10.57,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":239471267,"isCdr":false,"pbRate":4.82,"roa":"--","roe":"--","epsLYR":-0.524,"committee":0.112022,"marketValue":2778000000,"turnoverRate":0.0175,"status":1,"floatMarketCap":2777000000},"requestUrl":"/m/hq/s/000590","defaultTab":"news","newsList":[{"id":"2601789797","title":"古汉医药：1月5日高管罗怀青增持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601789797","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601789797?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:01","pubTimestamp":1767704507,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月6日市场公开信息、上市公司公告及交易所披露数据整理，古汉医药（000590）最新董监高及相关人员股份变动情况：2026年1月5日公司独立董事罗怀青共增持公司股份1.0万股，占公司总股本为0.0042%。变动期间公司股价上涨5.0%，1月5日当日收盘报11.77元。古汉医药近半年内的董监高及核心技术人员增减持详情如下：古汉医药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600040495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2595361799","title":"古汉医药(000590.SZ)：全资子公司股权内部划转","url":"https://stock-news.laohu8.com/highlight/detail?id=2595361799","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595361799?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:37","pubTimestamp":1767091032,"startTime":"0","endTime":"0","summary":"格隆汇12月30日丨古汉医药(000590.SZ)公布，为更好地发挥公司下属子公司之间的协同效应，优化资源配置，结合公司战略规划，拟将所持有的全资子公司广东先通药业有限公司(简称“广东先通”)100%股权划转至古汉中药有限公司(简称“中药公司”)。本次股权划转完成后，广东先通成为中药公司的全资子公司，成为公司的全资孙公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251230/31904100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0122","BK0239","000590"],"gpt_icon":0},{"id":"2593894344","title":"启迪药业最新公告：证券简称拟变更为“古汉医药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2593894344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593894344?lang=zh_cn&edition=full","pubTime":"2025-12-22 18:49","pubTimestamp":1766400581,"startTime":"0","endTime":"0","summary":"启迪药业(000590.SZ)公告称，公司第十届董事会临时会议于2025年12月22日召开，会议审议通过《关于变更公司证券简称的议案》。公司证券简称将由“启迪药业”变更为“古汉医药”，并向深圳证券交易所提交证券简称变更申请。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200024941.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","09939","BK1574","BK1515","159938","161027","BK0239","BK1161","000590"],"gpt_icon":0},{"id":"2591938313","title":"启迪药业（000590）披露拟变更公司名称并修订《公司章程》议案获股东会通过，12月16日股价下跌2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591938313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591938313?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:25","pubTimestamp":1765895108,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，启迪药业报收于10.63元，较前一交易日下跌2.83%，最新总市值为25.46亿元。近日，启迪药业集团股份公司发布2025年第三次临时股东会决议公告，宣布公司于2025年12月16日召开2025年第三次临时股东会，会议以现场与网络投票相结合的方式举行。公告显示，本次股东会审议通过了关于拟变更公司名称并修订《公司章程》的议案、修订《股东会议事规则》的议案及修订《董事会议事规则》的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600041019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2586240458","title":"启迪药业：通过产品及康养文旅服务对接养老产业链需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2586240458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586240458?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:48","pubTimestamp":1764247702,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业11月26日在投资者关系平台上答复投资者关心的问题。公司目前没有直接运营养老服务机构。公司现阶段主要通过产品、诊疗服务及康养文旅服务对接养老产业链需求。建成的古汉中药工业园区是集中医药智能制造观光、中医药文化科普研学、中医诊疗康养体验为一体的国家3A级工业旅游景区。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700035357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","399812","BK0122","000590"],"gpt_icon":0},{"id":"2586258872","title":"启迪药业(000590.SZ)拟更名为“古汉医药集团股份公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258872","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258872?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:49","pubTimestamp":1764150590,"startTime":"0","endTime":"0","summary":"智通财经APP讯，启迪药业(000590.SZ)公告，公司董事会审议通过了《关于拟变更公司名称并修订<公司章程>的议案》，同意将公司名称拟变更为“古汉医药集团股份公司”，并同步修订《公司章程》的相关条款。待公司名称变更完成后，公司将根据深圳证券交易所有关规定向其申请变更证券简称。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2584131510","title":"启迪药业：可治疗流感症状的药品有7个产品批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131510","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131510?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:48","pubTimestamp":1763642933,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业11月20日在投资者关系平台上答复投资者关心的问题。公司可治疗流感相应症状的药品有风寒感冒颗粒、风热感冒颗粒等7个产品批文，分别具有疏风散寒、清温解毒、止咳等功效；药食同源养生食品有：甘姜饮，源自张仲景的甘草干姜汤。中医讲究辨证论治，流感每个人的症状不同，应区分寒热虚实，或在医生指导下用药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2584996955","title":"启迪药业（000590）发布2025年第二次临时股东大会决议公告，11月18日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584996955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584996955?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:29","pubTimestamp":1763476162,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，启迪药业报收于11.9元，较前一交易日下跌1.0%，最新总市值为28.5亿元。该股当日开盘12.06元，最高12.09元，最低11.78元，成交额达4508.25万元，换手率为1.59%。近日，启迪药业集团股份公司披露了2025年第二次临时股东大会决议公告。出席会议股东共161人，代表股份占公司有表决权股份总数的45.4846%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800040013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2582653809","title":"股市必读：启迪药业（000590）11月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582653809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582653809?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:40","pubTimestamp":1762796427,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘，启迪药业报收于11.57元，上涨0.61%，换手率1.79%，成交量4.3万手，成交额4964.12万元。董秘最新回复投资者： 董秘您好！公司密切关注股价走势及市场动态，并将在合法合规的前提下，研究并探索有利于公司价值提升和股东权益保护的相关措施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100000655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0122","BK0239"],"gpt_icon":0},{"id":"2582876758","title":"启迪药业：取消变更公司名称议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2582876758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582876758?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:48","pubTimestamp":1762778903,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业11月10日在投资者关系平台上答复投资者关心的问题。2025年9月16日，公司第十届董事会临时会议审议通过了《关于取消2025年第一次临时股东大会部分提案的议案》，决定取消《关于拟变更公司名称并修改＜公司章程＞的议案》，原因是公司提交的“古汉养生健康产业集团股份公司”名称变更方案尚未获得市场监督管理部门审核通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000031894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2581940888","title":"启迪药业：公司目前没有筹划的定增事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2581940888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581940888?lang=zh_cn&edition=full","pubTime":"2025-11-07 20:51","pubTimestamp":1762519901,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业(000590)11月06日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，贵司是否有定增计划？以贵司现有的经营模式今年是否有望实现扭亏为盈？启迪药业回复：尊敬的投资者，您好！公司目前没有筹划的定增事项，未来如有相关计划，将严格依照法律法规要求，及时履行信息披露义务。年度业绩最终能否实现受市场环境等多重因素影响，存在不确定性，有关公司全年业绩的具体情况，请您关注后续相关公告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700036552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0239","BK0122"],"gpt_icon":0},{"id":"2579066641","title":"股市必读：启迪药业三季报 - 第三季度单季净利润同比增长146.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579066641","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579066641?lang=zh_cn&edition=full","pubTime":"2025-10-31 05:59","pubTimestamp":1761861554,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，启迪药业报收于12.58元，上涨2.61%，换手率5.83%，成交量13.96万手，成交额1.74亿元。业绩披露要点财务报告2025年前三季度，公司主营收入2.25亿元，同比增长3.97%；归母净利润-1482.06万元，同比增长47.91%；扣非净利润-2068.18万元，同比增长35.13%。2025年第三季度，公司单季度主营收入8237.83万元，同比增长18.4%；单季度归母净利润234.95万元，同比增长146.43%；单季度扣非净利润197.03万元，同比增长126.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100006850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"gpt_icon":0},{"id":"2579873191","title":"图解启迪药业三季报：第三季度单季净利润同比增长146.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579873191","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579873191?lang=zh_cn&edition=full","pubTime":"2025-10-30 02:51","pubTimestamp":1761763864,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业2025年三季报显示，前三季度公司主营收入2.25亿元，同比上升3.97%；归母净利润-1482.06万元，同比上升47.91%；扣非净利润-2068.18万元，同比上升35.13%；其中2025年第三季度，公司单季度主营收入8237.83万元，同比上升18.4%；单季度归母净利润234.95万元，同比上升146.43%；单季度扣非净利润197.03万元，同比上升126.29%；负债率38.04%，投资收益9.23万元，财务费用222.94万元，毛利率46.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000002874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590"],"gpt_icon":0},{"id":"2577780143","title":"10月23日启迪药业（000590）涨停分析：控股股东变更、业绩改善驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2577780143","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577780143?lang=zh_cn&edition=full","pubTime":"2025-10-23 15:23","pubTimestamp":1761204227,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业10月23日涨停收盘，收盘价12.68元。今日启迪药业涨停的可能因素有：控股股东变更引发市场对业务协同预期，湖南赛乐仙入主后拟更名聚焦大健康产业；2025年上半年净亏损同比收窄26.61%，经营活动现金流显著改善；中药及大健康板块热度提升形成板块联动效应，叠加雄安新区、AI医疗等概念催化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300017939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0239","BK0122"],"gpt_icon":0},{"id":"2577074878","title":"启迪药业：暂无海外业务或出口收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2577074878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577074878?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:51","pubTimestamp":1761051097,"startTime":"0","endTime":"0","summary":"证券之星消息，启迪药业(000590)10月20日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司产品是否出口，是否出口欧盟等国家？启迪药业回复：尊敬的投资者您好，公司暂无海外业务或出口收入，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100034612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2570058959","title":"启迪药业、盟科药业易主，医药行业加速洗牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2570058959","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570058959?lang=zh_cn&edition=full","pubTime":"2025-09-25 08:50","pubTimestamp":1758761400,"startTime":"0","endTime":"0","summary":" 近日，启迪药业、盟科药业控制权变更的消息引发市场广泛关注。而随着股东和管理层的变动，启迪药业也将迎来自上市以来的第6次更名。 资本市场风云激荡，企业控制权变动背后，既是资本对医药赛道价值的再判断，也是行业加速洗牌的缩影。对启迪药业、盟科药业而言，如何依托新股东资源完成业务聚焦、稳定经营预期，将是决定其能否在行业变革中突围的关键。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-09-25/doc-infrsfyt0926979.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-09-25/doc-infrsfyt0926979.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0122","000590","BK0239","688373"],"gpt_icon":0},{"id":"2569771013","title":"启迪药业最新公告：独立董事黄正明因工作原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2569771013","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569771013?lang=zh_cn&edition=full","pubTime":"2025-09-24 17:10","pubTimestamp":1758705015,"startTime":"0","endTime":"0","summary":"启迪药业(000590.SZ)公告称，公司独立董事黄正明因工作原因决定辞去公司独立董事等职务。黄正明的辞职将导致公司独立董事人数不足《公司章程》规定的董事会人数的三分之一。根据相关法律法规，黄正明的辞职报告将在公司股东大会选举产生新任独立董事后生效。在此期间，他将继续履行独立董事及相关委员会职责。公司将尽快完成独立董事的补选工作。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400029460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0122","000590"],"gpt_icon":0},{"id":"2569814117","title":"启迪药业最新公告：总裁冯雪、副总裁蔡军辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2569814117","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569814117?lang=zh_cn&edition=full","pubTime":"2025-09-22 19:50","pubTimestamp":1758541847,"startTime":"0","endTime":"0","summary":"启迪药业(000590.SZ)公告称，公司近日收到总裁冯雪和副总裁蔡军的辞职报告。冯雪因工作变动辞去总裁职务，蔡军因职业规划原因辞去副总裁职务。两人辞职后将不再担任公司任何职务。公司对他们在任期间的贡献表示感谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200030089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000590","BK0239","BK0122"],"gpt_icon":0},{"id":"2568645124","title":"启迪药业（000590）披露取消2025年第一次临时股东大会部分提案，9月17日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568645124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568645124?lang=zh_cn&edition=full","pubTime":"2025-09-17 17:26","pubTimestamp":1758101191,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，启迪药业报收于12.4元，较前一交易日上涨0.57%，最新总市值为29.69亿元。该股当日开盘12.3元，最高12.65元，最低12.23元，成交额达1.06亿元，换手率为3.56%。公司于近日发布公告称，启迪药业集团股份公司第十届董事会临时会议于2025年9月16日以通讯表决方式召开，应参加董事5人，实际参加5人。本次取消提案程序符合相关规定。除上述取消提案外，2025年第一次临时股东大会其他事项不变。表决结果：5票赞成，0票反对，0票弃权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700030239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","000590","BK0239"],"gpt_icon":0},{"id":"2565555474","title":"启迪药业(000590.SZ)拟更名为“古汉养生健康产业集团股份公司”","url":"https://stock-news.laohu8.com/highlight/detail?id=2565555474","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565555474?lang=zh_cn&edition=full","pubTime":"2025-09-05 18:44","pubTimestamp":1757069084,"startTime":"0","endTime":"0","summary":"智通财经APP讯，启迪药业(000590.SZ)公告，公司董事会同意将公司名称拟变更为“古汉养生健康产业集团股份公司”，并同步修订《公司章程》的相关条款。待公司名称变更完成后，公司将根据深圳证券交易所有关规定向其申请变更证券简称，公司证券代码保持不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0122","000590","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767773269770,"stockEarnings":[{"period":"1week","weight":0.0751},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0226},{"period":"6month","weight":-0.1186},{"period":"1year","weight":0.7842},{"period":"ytd","weight":0.0473}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"古汉医药集团股份公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17617人(较上一季度增加17.25%)","perCapita":"13587股","listingDate":"1996-01-19","address":"湖南省衡阳市蒸湘区高新区杨柳路33号","registeredCapital":"23947万元","survey":" 古汉医药集团股份公司的主营业务是医药大健康领域的拓展深耕，产品涵盖中药、化药、保健食品三大板块。公司的主要产品是补益养生类药品、心脑血管类药品、儿童营养类药品、感冒类药品、清热解毒类药品。公司为国家级绿色工厂、中国驰名商标、中华老字号、湖南省非物质文化遗产代表性名录、湖南省制造业质量标杆称号。","listedPrice":6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"古汉医药(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供古汉医药(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"古汉医药,000590,古汉医药股票,古汉医药股票老虎,古汉医药股票老虎国际,古汉医药行情,古汉医药股票行情,古汉医药股价,古汉医药股市,古汉医药股票价格,古汉医药股票交易,古汉医药股票购买,古汉医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"古汉医药(000590)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供古汉医药(000590)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}